134 related articles for article (PubMed ID: 36376377)
1. VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia.
Sher S; Whipp E; Walker J; Zhang P; Beaver L; Williams K; Orwick S; Ravikrishnan J; Walker B; Perry E; Gregory C; Purcell M; Pan A; Yan P; Alinari L; Johnson AJ; Frigault MM; Greer JM; Hamdy A; Izumi R; Mo X; Sampath D; Woyach J; Blachly J; Byrd JC; Lapalombella R
Leukemia; 2023 Feb; 37(2):326-338. PubMed ID: 36376377
[TBL] [Abstract][Full Text] [Related]
2. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
Dow EC; Liu H; Rice AP
J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
[TBL] [Abstract][Full Text] [Related]
3. The CDK9/cyclin T1 subunits of P-TEFb in mouse oocytes and preimplantation embryos: a possible role in embryonic genome activation.
Oqani RK; Kim HR; Diao YF; Park CS; Jin DI
BMC Dev Biol; 2011 Jun; 11():33. PubMed ID: 21639898
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
[TBL] [Abstract][Full Text] [Related]
5. Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb.
Jamaluddin MS; Hu PW; Jan Y; Siwak EB; Rice AP
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):169-73. PubMed ID: 26727990
[TBL] [Abstract][Full Text] [Related]
6. Changing for the Better: Discovery of the Highly Potent and Selective CDK9 Inhibitor VIP152 Suitable for Once Weekly Intravenous Dosing for the Treatment of Cancer.
Lücking U; Kosemund D; Böhnke N; Lienau P; Siemeister G; Denner K; Bohlmann R; Briem H; Terebesi I; Bömer U; Schäfer M; Ince S; Mumberg D; Scholz A; Izumi R; Hwang S; von Nussbaum F
J Med Chem; 2021 Aug; 64(15):11651-11674. PubMed ID: 34264057
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.
Mbonye UR; Gokulrangan G; Datt M; Dobrowolski C; Cooper M; Chance MR; Karn J
PLoS Pathog; 2013; 9(5):e1003338. PubMed ID: 23658523
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of P-TEFb disrupts global transcription, oocyte maturation, and embryo development in the mouse.
Oqani RK; Lin T; Lee JE; Kim SY; Sa SJ; Woo JS; Jin DI
Genesis; 2016 Sep; 54(9):470-82. PubMed ID: 27488304
[TBL] [Abstract][Full Text] [Related]
9. CDK9 Inhibitor Induces Apoptosis, Autophagy, and Suppression of Tumor Growth in Adult T-Cell Leukemia/Lymphoma.
Kato N; Kozako T; Ohsugi T; Uchida Y; Yoshimitsu M; Ishitsuka K; Aikawa A; Honda SI
Biol Pharm Bull; 2023; 46(9):1269-1276. PubMed ID: 37661406
[TBL] [Abstract][Full Text] [Related]
10. Disrupting the Cdk9/Cyclin T1 heterodimer of 7SK snRNP for the Brd4 and AFF1/4 guided reconstitution of active P-TEFb.
Zhou K; Zhuang S; Liu F; Chen Y; Li Y; Wang S; Li Y; Wen H; Lin X; Wang J; Huang Y; He C; Xu N; Li Z; Xu L; Zhang Z; Chen LF; Chen R; Liu M
Nucleic Acids Res; 2022 Jan; 50(2):750-762. PubMed ID: 34935961
[TBL] [Abstract][Full Text] [Related]
11. Acute hypoxia affects P-TEFb through HDAC3 and HEXIM1-dependent mechanism to promote gene-specific transcriptional repression.
Safronova OS; Nakahama K; Morita I
Nucleic Acids Res; 2014 Aug; 42(14):8954-69. PubMed ID: 25056306
[TBL] [Abstract][Full Text] [Related]
12. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
[TBL] [Abstract][Full Text] [Related]
13. P-TEFb kinase complex phosphorylates histone H1 to regulate expression of cellular and HIV-1 genes.
O'Brien SK; Cao H; Nathans R; Ali A; Rana TM
J Biol Chem; 2010 Sep; 285(39):29713-20. PubMed ID: 20551309
[TBL] [Abstract][Full Text] [Related]
14. Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells.
Kruse U; Pallasch CP; Bantscheff M; Eberhard D; Frenzel L; Ghidelli S; Maier SK; Werner T; Wendtner CM; Drewes G
Leukemia; 2011 Jan; 25(1):89-100. PubMed ID: 20944678
[TBL] [Abstract][Full Text] [Related]
15. Polo-like kinase 1 inhibits the activity of positive transcription elongation factor of RNA Pol II b (P-TEFb).
Jiang L; Huang Y; Deng M; Liu T; Lai W; Ye X
PLoS One; 2013; 8(8):e72289. PubMed ID: 23977272
[TBL] [Abstract][Full Text] [Related]
16. Short communication: SAHA (vorinostat) induces CDK9 Thr-186 (T-loop) phosphorylation in resting CD4+ T cells: implications for reactivation of latent HIV.
Ramakrishnan R; Liu H; Rice AP
AIDS Res Hum Retroviruses; 2015 Jan; 31(1):137-41. PubMed ID: 24528253
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of a dual Cdc7/Cdk9 kinase inhibitor against quiescent and proliferating CLL cells.
Natoni A; Murillo LS; Kliszczak AE; Catherwood MA; Montagnoli A; Samali A; O'Dwyer M; Santocanale C
Mol Cancer Ther; 2011 Sep; 10(9):1624-34. PubMed ID: 21768328
[TBL] [Abstract][Full Text] [Related]
18. CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation.
Cho S; Schroeder S; Ott M
Cell Cycle; 2010 May; 9(9):1697-705. PubMed ID: 20436276
[TBL] [Abstract][Full Text] [Related]
19. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
[TBL] [Abstract][Full Text] [Related]
20. Transcription Elongation Factor P-TEFb Is Involved in IL-17F Signaling in Airway Smooth Muscle Cells.
Nakajima M; Kawaguchi M; Matsuyama M; Ota K; Fujita J; Matsukura S; Huang SK; Morishima Y; Ishii Y; Satoh H; Sakamoto T; Hizawa N
Int Arch Allergy Immunol; 2018; 176(2):83-90. PubMed ID: 29649811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
